To test if non-neuronal HSP-SPAST patient cells have disease-associated pathology of reduced acetylated α-tubulin, we compared the expression of acetylated α-tubulin in PBMCs from 9 HSP-SPAST patients and 11 healthy control PBMCs. This evidence concerns the gene HSP90B2P and hereditary spastic paraplegia.